NCT05796635

An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Focus Consumer Healthcare · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.

Conditions

• Cold Sores

Interventions

Type	Name	Description
OTHER	Herpecin L	Participants in the Herpecin L arm will use the test product daily as a preventive product by applying the product twice daily. Also, participants will be told they can reapply the product if going outside into the cold, wind, or sun. If participants in the Herpecin L arm do experience a cold sore or fever blister, they will be instructed to use the product at the first sign of the cold sore and then at least four more times during the day until the cold sore is gone (they can use the product more often if they plan to go outside into the cold, sun, or wind).

Timeline

• Start date: 2023-01-04
• Primary completion: 2023-01-26
• Completion: 2023-02-20
• First posted: 2023-04-03
• Last updated: 2023-04-03

Locations

1 site across 1 country: United States